Effects of electroconvulsive therapy on plasma levels of neuroactive steroids in inpatients with major depression

References

• Akdemir A, Orsel S, Dağ I, Türkçapar H, Işcan N, Ozbay H. 1996. The Turkish validity and reliability of Hamilton Depression Rating Scale and its use in clinical practice. Journal of Psikiyatri Psikoloji Psikofarmakoloji 4:251–259 (in Turkish).
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders IV, Text Revision (DSM-IV-TR).
   Google Scholar
• Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, et al. 2004. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res 128:117–122.
   PubMed Web of Science ®Google Scholar
• Baghai TC, di Michele F, Schule C, Eser D, Zwanzger P, Pasini A, et al. 2005. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology 30:1181–1186.
   PubMedGoogle Scholar
• Bayar R, Emul M, Turan S, Zerdali H, Salihoglu T, Duran A, et al. 2009. Electrocardiographical P wave changes after electroconvulsive therapy in patients with schizophrenia: a preliminary study. J ECT 25:26–30.
   Google Scholar
• Dubrovsky B. 2006. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol Biochem Behav 84:644–655.
   PubMed Web of Science ®Google Scholar
• Eser D, Schule C, Baghai TC, Romeo E, Uzunov DP, Rupprecht R. 2006. Neuroactive steroids and affective disorders. Pharmacol Biochem Behav 84:656–666.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960.A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
   PubMed Web of Science ®Google Scholar
• Khisti RT, Chopde CT, Jain SP. 2000. Antidepressant-like effect of the neurosteroid 3 alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67:137–143.
   PubMed Web of Science ®Google Scholar
• Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, et al. 2013. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord 146:205–212.
   PubMed Web of Science ®Google Scholar
• Maayan R, Morad O, Dorfman P, Overstreet DH, Weizman A, Yadid G. 2005. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression. Eur Neuropsychopharmacol 15:253–262.
   Google Scholar
• Maayan R, Yagorowski Y, Grupper D, Weiss M, Shtaif B, Kaoud MA, et al. 2000. Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients. Biol Psychiatry 48: 693–701.
   PubMed Web of Science ®Google Scholar
• Maurice T, Roman FJ, Privat A. Modulation by neurosteroids of the in vivo (+)-[3H] SKF-10,047 binding to sigma 1 receptors in the mouse forebrain. 1996. J Neurosci Res 46: 734–743.
   PubMed Web of Science ®Google Scholar
• McHenry J, Carrier N, Hull E, Kabbaj M. 2014. Sex differences in anxiety and depression: Role of testosterone. Front Neuroendocrinol 35:42–57.
   PubMed Web of Science ®Google Scholar
• Meieran SE, Reus VI, Webster R, Shafton R, Wolkowitz OM. 2004. Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology 29: 486–500.
   Google Scholar
• Ozsoy S, Esel E, Hacimusalar Y, Candan Z, Kula M, Turan T. 2008. Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder. Turk Psikiyatri Derg 19:341–348.
   Google Scholar
• Padberg F, di Michele F, Zwanzger R, Romeo E, Bernardi G, Schule C, et al. 2002. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in depression. Neuropsychopharmacology 27:874–878.
   PubMedGoogle Scholar
• Palinkas L, Barret-Connor E. 1992. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80: 30–36.
   PubMed Web of Science ®Google Scholar
• Romeo E, Strohle A, Spaelleta G, di Michele F, Herman B, Holsboer F. 1998. Effects of antidepressant treatment on neuractive steroids in major depression. Am J Psychiatry 155:910–913.
   PubMed Web of Science ®Google Scholar
• Rupprecht R. 2003. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28:139–168.
   PubMed Web of Science ®Google Scholar
• Schule C, di Michele F, Baghai T, Romeo E, Bernardi G, Zwanzger R. 2003. Influence of sleep deprivation on neuroactive steroids in major depression. Neuropsychopharmacology 28:577–581.
   PubMed Web of Science ®Google Scholar
• Strohle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, et al. 1999. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274–277.
   PubMed Web of Science ®Google Scholar
• Urani A, Roman FJ, Phan VL, Su TP, Maurice T. 2001. The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther 298:1269–1279.
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, et al. 1998. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci 95:3239–3244.
   PubMed Web of Science ®Google Scholar
• Uzunova V, Wrynn AS, Kinnunen A, Ceci M, Kohler C, Uzunov DP. 2004. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486:31–34.
   PubMed Web of Science ®Google Scholar
• Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. 1999. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156: 646–649.
   PubMed Web of Science ®Google Scholar